Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing
Patent
1994-10-21
1996-04-09
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
514 21, 514 25, 514 53, 514177, 514179, 514182, A61K 3843, A61K 3800, A61K 3170, A61K 31715
Patent
active
055059422
ABSTRACT:
The present invention relates to the use of hydrolytic enzymes for the prophylaxis of spontaneous abortion in pregnant women in need thereof with habitual idiophathic abortion in their anamneses.
REFERENCES:
patent: 5140100 (1992-08-01), Braunstein et al.
patent: 5276017 (1994-01-01), Feinberg et al.
Chemical Abstracts, vol. 88, No. 19 issued 19 May 1978, Stepanova et al., "Some indexes of the adrenal cortex function in children whose mothers were treated with steriod hormones during pregnancy for habitual miscarriage" see p. 85, column 2, abstract No. 131344e, Vopr. Okhr. Materin. Det., 22(9), 34-5.
Chemical Abstracts, vol. 98, No. 7 issued 25 Feb. 1983, Kitagawa et al., "Prevention of habitual abortion in cows with 17-.alpha.-hydroxyprogesterone caproate and progesterone level in milk" see p. 93, column 2 and 94, column 1, abstract No. 47132h, Nippon Juishikai Zasshi, 35(7), 398-401.
Dittmar Friedrich-Wilhelm
Kunze Rudolf
Ransberger Karl
Stauder Gerhard
Cintins Marianne M.
Mucos Pharma GmbH & Co.
Weddington Kevin E.
LandOfFree
Use of hydrolytic enzymes for the prophylaxis of spontaneous abo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of hydrolytic enzymes for the prophylaxis of spontaneous abo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hydrolytic enzymes for the prophylaxis of spontaneous abo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-137093